InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Stuart Iain, Directeur Scientifique. Director active across 1 company, notably VYNE Therapeutics Inc.. Aggregated, 24 filings have been published. Activity tracked since 30 June 2021. The latest transaction was disclosed on 23 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Stuart Iain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
15,405 股@ US$0.89760.045% mcap18.4% 占其流量Common StockSEC:0001727756-26-000008:0
2,876 股@ US$0.59753.1% 占其流量Common StockSEC:0001727756-26-000004:0
2,448 股@ US$0.58012.2% 占其流量Common StockSEC:0001727756-26-000002:0
2,453 股@ US$0.3351.3% 占其流量Common StockSEC:0001727756-25-000003:0
2,453 股@ US$1.656.6% 占其流量Common StockSEC:0001415889-25-019058:0
6,044 股@ US$1.5815.0% 占其流量Common StockSEC:0001415889-25-009632:0
4,857 股@ US$3.3526.5% 占其流量Common StockSEC:0001415889-25-000155:0
109 股@ US$1.880.3% 占其流量Common StockSEC:0001415889-24-024382:0
138 股@ US$1.920.4% 占其流量Common StockSEC:0001415889-24-019175:0
157 股@ US$3.080.8% 占其流量Common StockSEC:0001415889-24-010070:0
62,500 股0Common StockSEC:0001209191-24-000469:0
62,500 股0Common StockSEC:0001209191-23-058818:0
1,184 股@ US$3.837.3% 占其流量Common StockSEC:0001209191-23-051948:0
151 股@ US$4.101.0% 占其流量Common StockSEC:0001209191-23-041120:0
480 股@ US$3.082.3% 占其流量Common StockSEC:0001209191-23-022801:0
1,720 股@ US$0.150.4% 占其流量Common StockSEC:0001209191-23-001098:0
1,719 股@ US$0.2230.7% 占其流量Common StockSEC:0001209191-22-052356:0
1,719 股@ US$0.3891.1% 占其流量Common StockSEC:0001209191-22-040788:0
3,469 股@ US$0.653.1% 占其流量Common StockSEC:0001209191-22-022530:0
75,000 股0Common StockSEC:0001209191-22-020066:0
1,250 股@ US$1.021.7% 占其流量Common StockSEC:0001209191-22-000858:0
1,480 股@ US$1.392.7% 占其流量Common StockSEC:0001209191-21-058519:0
60,859 股0Common StockSEC:0001209191-21-054836:0
3,083 股@ US$3.5117.0% 占其流量Common StockSEC:0001209191-21-044979:0
24 条申报中的 24 条
About Stuart Iain
Stuart Iain is Chief Scientific Officer at VYNE Therapeutics Inc. He has 23 filings in total, and among the sampled recent filings the most common transaction nature is Tax withholding, with buy and sell amounts of 0, over the period from 2021-07-02 to 2026-04-02.
